Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Proteotype-1.5M-Grant

More Like This

PR Newswire associated0

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

PR Newswire associated0

Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

PR Newswire associated0

Proteotype Unveils Alchemi®, the Data and Orchestration Platform Behind Enlighten®

PR Newswire associated0

Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

PR Newswire associated0

Innovative Immunodiagnostic Platform Unveils Highly Sensitive Cancer Early-Detection Test with Predictive Treatment Insights

New ‘Super Test’ for Prostate Cancer Developed in the UK by EDX Medical

New Government tech deals boost the business of cancer detection

PR Newswire associated0

Sengenics Corporation Unveils i-Ome® Cancer: A Breakthrough in Cancer Precision Medicine